LONDON (Alliance News) - IXICO PLC said Thursday it will net additional GBP500,000 from expansion of existing clinical trial services contract with two biopharmaceutical companies.
The contract amendment reflects an expansion in the scope of IXICO's PET and MRI neuroimaging clinical trial services, with IXICO providing additional specialist services during the contract period.
The contract expansion will increase the combined value of the contracts to GBP2.4 million.
Shares in the neuroscience-focused digital technologies company were down 3.3% at 30.00 pence.
Ixico (IXI)